Top Markets
Coin of the day
Acepodia, Inc. Acepodia, Inc.

Acepodia, Inc.

6976
Clasificación en acciones #17951
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering... Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
Precio por acción
$0.37522853
Capitalización bursátil
$217.81M
Cambio (1 día)
-0.84%
Cambio (1 año)
-27.92%
País
KY
Comercio Acepodia, Inc. (6976)

Categoría

Ratio P/B de Acepodia, Inc. (6976)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Acepodia, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Acepodia, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH